Literature DB >> 33778084

Pulmonary Artery Filling Defects in COVID-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication?

Arnaldo Scardapane1, Laura Villani1, Davide Fiore Bavaro2, Francesca Passerini3, Amato Antonio Stabile Ianora1, Nicola Maria Lucarelli1, Gioacchino Angarano2, Piero Portincasa3, Vincenzo Ostilio Palmieri3, Annalisa Saracino2.   

Abstract

PURPOSE: This study is aimed at assessing the prevalence of pulmonary artery filling defects (PAFDs) consistent with pulmonary artery embolism (PAE) in patients with SARS-CoV-2 infection and at investigating possible radiological or clinical predictors.
MATERIALS AND METHODS: Computed Tomography Pulmonary Angiographies (CTPAs) from 43 consecutive patients with a confirmed COVID-19 infection were retrospectively reviewed, taking into consideration the revised Geneva score and the D-dimer value for each patient. Filling defects within the pulmonary arteries were recorded along with pleural and parenchymal findings such as ground glass opacities, consolidation, crazy paving, linear consolidation, and pleural effusion. All these variables were compared between patients with and without PAFD. The predictive performance of statistically different parameters was investigated using the receiver operating characteristics (ROC).
RESULTS: Pulmonary embolism was diagnosed in 15/43 patients (35%), whereas CTPA and parenchymal changes related to pulmonary COVID-19 disease were evident in 39/43 patients (91%). The revised Geneva score and the mean D-dimer value obtained using two consecutive measurements were significantly higher in patients with PAFD. The ROC analysis demonstrated that a mean D-dimer value is the parameter with the higher predictivity (AUC 0.831) that is a cut-off value > 1800 μg/l which predicts the probability of PAFD with a sensitivity and specificity of 70% and 78%, respectively.
CONCLUSIONS: This single centre retrospective report shows a high prevalence of pulmonary artery filling defects revealed using CTPA in COVID-19 patients and demonstrates that the mean value of multiple D-dimer measurements may represent a predicting factor of this complication.
Copyright © 2021 Arnaldo Scardapane et al.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33778084      PMCID: PMC7958141          DOI: 10.1155/2021/8851736

Source DB:  PubMed          Journal:  Biomed Res Int            Impact factor:   3.411


  29 in total

1.  Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis.

Authors:  Fabio Ciceri; Luigi Beretta; Anna Mara Scandroglio; Sergio Colombo; Giovanni Landoni; Annalisa Ruggeri; Jacopo Peccatori; Armando D'Angelo; Francesco De Cobelli; Patrizia Rovere-Querini; Moreno Tresoldi; Lorenzo Dagna; Alberto Zangrillo
Journal:  Crit Care Resusc       Date:  2020-04-15       Impact factor: 2.159

2.  Prediction of pulmonary embolism in the emergency department: the revised Geneva score.

Authors:  Grégoire Le Gal; Marc Righini; Pierre-Marie Roy; Olivier Sanchez; Drahomir Aujesky; Henri Bounameaux; Arnaud Perrier
Journal:  Ann Intern Med       Date:  2006-02-07       Impact factor: 25.391

3.  Chest CT Findings in 2019 Novel Coronavirus (2019-nCoV) Infections from Wuhan, China: Key Points for the Radiologist.

Authors:  Jeffrey P Kanne
Journal:  Radiology       Date:  2020-02-04       Impact factor: 11.105

4.  Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected with Pulmonary CT Angiography.

Authors:  Franck Grillet; Julien Behr; Paul Calame; Sébastien Aubry; Eric Delabrousse
Journal:  Radiology       Date:  2020-04-23       Impact factor: 11.105

5.  Endothelial cell infection and endotheliitis in COVID-19.

Authors:  Zsuzsanna Varga; Andreas J Flammer; Peter Steiger; Martina Haberecker; Rea Andermatt; Annelies S Zinkernagel; Mandeep R Mehra; Reto A Schuepbach; Frank Ruschitzka; Holger Moch
Journal:  Lancet       Date:  2020-04-21       Impact factor: 79.321

6.  COVID-19 Complicated by Acute Pulmonary Embolism and Right-Sided Heart Failure.

Authors:  Waqas Ullah; Rehan Saeed; Usman Sarwar; Rajesh Patel; David L Fischman
Journal:  JACC Case Rep       Date:  2020-04-17

7.  Acute Pulmonary Embolism and COVID-19.

Authors:  Neo Poyiadji; Peter Cormier; Parth Y Patel; Mohamad O Hadied; Pallavi Bhargava; Kanika Khanna; Jeffrey Nadig; Thomas Keimig; David Spizarny; Nicholas Reeser; Chad Klochko; Edward L Peterson; Thomas Song
Journal:  Radiology       Date:  2020-05-14       Impact factor: 11.105

8.  Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?

Authors:  Marco Cattaneo; Elena M Bertinato; Simone Birocchi; Carolina Brizio; Daniele Malavolta; Marco Manzoni; Gesualdo Muscarella; Michela Orlandi
Journal:  Thromb Haemost       Date:  2020-04-29       Impact factor: 5.249

Review 9.  The role of imaging in 2019 novel coronavirus pneumonia (COVID-19).

Authors:  Wenjing Yang; Arlene Sirajuddin; Xiaochun Zhang; Guanshu Liu; Zhongzhao Teng; Shihua Zhao; Minjie Lu
Journal:  Eur Radiol       Date:  2020-04-15       Impact factor: 5.315

10.  Pulmonary embolism in patients with COVID-19: Time to change the paradigm of computed tomography.

Authors:  D C Rotzinger; C Beigelman-Aubry; C von Garnier; S D Qanadli
Journal:  Thromb Res       Date:  2020-04-11       Impact factor: 3.944

View more
  5 in total

1.  COVID-19 in Italy: Comparison of CT Findings from Time Zero to the Delta Variant.

Authors:  Nicola Maggialetti; Ilaria Villanova; Annalisa Castrì; Chiara Noemi Greco; Francesco Inchingolo; Daniele Virgilio; Marco Moschetta; Angela Sardaro; Amato Antonio Stabile Ianora; Arnaldo Scardapane
Journal:  Microorganisms       Date:  2022-04-09

2.  COUNTERPOINT: Should Therapeutic Heparin Be Administered to Acutely Ill Hospitalized Patients With COVID-19? No.

Authors:  David Jimenez; Parth Rali; Kevin Doerschug
Journal:  Chest       Date:  2022-03-15       Impact factor: 10.262

Review 3.  [Utility of probability scores for the diagnosis of pulmonary embolism in patients with SARS-CoV-2 infection: a systematic review].

Authors:  Ana Isabel Franco-Moreno; Ana Bustamante-Fermosel; José Manuel Ruiz-Giardin; Nuria Muñoz-Rivas; Juan Torres-Macho; David Brown-Lavalle
Journal:  Rev Clin Esp       Date:  2022-08-05       Impact factor: 3.064

Review 4.  Effectiveness of SARS-CoV-2 Vaccines for Short- and Long-Term Immunity: A General Overview for the Pandemic Contrast.

Authors:  Alessio Danilo Inchingolo; Giuseppina Malcangi; Sabino Ceci; Assunta Patano; Alberto Corriero; Luigi Vimercati; Daniela Azzollini; Grazia Marinelli; Giovanni Coloccia; Fabio Piras; Giuseppe Barile; Vito Settanni; Antonio Mancini; Nicole De Leonardis; Grazia Garofoli; Giulia Palmieri; Ciro Gargiulo Isacco; Biagio Rapone; Arnaldo Scardapane; Luigi Curatoli; Nicola Quaranta; Mario Ribezzi; Maria Massaro; Megan Jones; Ioana Roxana Bordea; Gianluca Martino Tartaglia; Antonio Scarano; Felice Lorusso; Luigi Macchia; Angela Maria Vittoria Larocca; Sergey Khachatur Aityan; Silvio Tafuri; Pasquale Stefanizzi; Giovanni Migliore; Nicola Brienza; Gianna Dipalma; Gianfranco Favia; Francesco Inchingolo
Journal:  Int J Mol Sci       Date:  2022-07-30       Impact factor: 6.208

Review 5.  Utility of probability scores for the diagnosis of pulmonary embolism in patients with SARS-CoV-2 infection: A systematic review.

Authors:  A I Franco-Moreno; A Bustamante-Fermosel; J M Ruiz-Giardin; N Muñoz-Rivas; J Torres-Macho; D Brown-Lavalle
Journal:  Rev Clin Esp (Barc)       Date:  2022-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.